Buy Advair Diskus
Advair Diskus

$106.55
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Prescription
Issued on site / Included
Availability
In Stock
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Advair Diskus Properties

Primary Category
Pharmacological Class
Inhaled Corticosteroid, Long‑Acting Beta‑2 Agonist, Combination Inhaler
Moderate Side Effects
Dosage Forms
Dry Powder Inhaler
Administration Route
Inhalation
Mechanism of Action
The inhaler delivers a steroid to reduce airway inflammation and a long‑acting bronchodilator to relax airway muscles, helping keep breathing easy over the day.
Prescription Status
Rx
Manufacturer
GlaxoSmithKline
Patient Summary
A combined inhaler that helps control asthma and COPD symptoms by reducing inflammation and opening the airways.
Onset Time
Within minutes
Duration
Provides relief for up to 12 hours
Storage Instructions
Store at room temperature, keep the device dry
Age Restrictions
Not for children under 4 years old
Pregnancy Use
Consult doctor before use during pregnancy

About Advair Diskus

Advair Diskus is a prescription inhaler that combines the corticosteroid fluticasone propionate with the long-acting β2-agonist salmeterol xinafoate. It belongs to the inhaled corticosteroid/long-acting beta-agonist (ICS/LABA) class and is used to prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD) in adults. While its primary indication is maintenance therapy, clinicians sometimes consider it for severe asthma that is not controlled by lower-dose inhalers.

What is Advair Diskus?

Advair Diskus is a brand-name, fixed-dose dry-powder inhaler approved by the Therapeutic Goods Administration (TGA) in Australia. The device delivers a precise mixture of fluticasone propionate and salmeterol xinafoate in three strength options: 100 µg/50 µg, 250 µg/50 µg, and 500 µg/50 µg per inhalation. GSK (GlaxoSmithKline) markets the product globally, and several generic versions are also available in Australia under the same active ingredients.

How Advair Diskus Works

The inhaler releases an aerosolized powder that reaches the airway lining when the patient inhales forcefully. Fluticasone binds to glucocorticoid receptors in airway epithelial cells, suppressing the transcription of inflammatory cytokines, chemokines and adhesion molecules. This reduces airway edema, mucus hypersecretion, and hyper-responsiveness. Salmeterol binds to β2-adrenergic receptors on airway smooth muscle, activating adenylate cyclase and increasing cyclic AMP. The resulting rise in intracellular cAMP relaxes the smooth muscle, producing bronchodilation that lasts about 12 hours. The synergy of anti-inflammatory and bronchodilator actions provides both immediate relief of bronchoconstriction and long-term control of airway inflammation. After inhalation, the drug is absorbed rapidly; fluticasone undergoes extensive first-pass metabolism, while salmeterol is metabolised mainly by CYP3A4. The onset of bronchodilation is within minutes, and the anti-inflammatory effect builds over several days of regular use.

Why Advair Diskus Is Used for Respiratory Conditions

  • Asthma maintenance - The combination addresses two key pathophysiological processes: inflammation (fluticasone) and reversible bronchoconstriction (salmeterol). Guidelines such as the GINA strategy list an ICS/LABA as step 3 or 4 therapy for patients whose asthma is not controlled on low-dose ICS alone.
  • COPD maintenance - Long-acting bronchodilation improves FEV₁ and reduces exacerbation frequency. The drug’s once-daily dosing aligns with guideline recommendations for patients with moderate-to-severe COPD who experience persistent symptoms despite a single bronchodilator.
  • Improved adherence - The Diskus device provides a consistent dose with each inhalation, helping patients avoid the timing errors sometimes seen with separate inhalers.
  • Dose flexibility - The three available strengths allow clinicians to titrate therapy according to symptom severity and lung-function measurements, supporting personalized treatment.

Off-Label and Investigational Uses of Advair Diskus

Limited peer-reviewed data explore the use of the combination in bronchiectasis and allergic rhinitis, but neither indication has received regulatory approval in Australia. Small-scale trials suggest modest reductions in sputum purulence in bronchiectasis, yet the evidence remains preliminary. Off-label use should only be considered under the supervision of a qualified healthcare provider.

Is Advair Diskus Right for You?

Patients who experience daily symptoms despite low-dose inhaled steroids, or who have frequent nighttime awakenings, often benefit from the added bronchodilator. It is generally appropriate for adults with moderate-to-severe asthma or COPD who can master the inhalation technique. Caution is advised for pregnant or lactating women; while data do not show major teratogenic risk, the medication should be continued only if the expected benefit outweighs potential fetal exposure. Individuals with severe hepatic impairment may require dose adjustment, whereas the inhaled route minimizes systemic exposure. Renal dysfunction does not significantly alter drug clearance.

Taking Advair Diskus Effectively

  • Timing: Use the inhaler at the same time each day, preferably in the morning, to maintain steady bronchodilation.
  • Technique: Open the Diskus to the “click” position, exhale fully, then inhale forcefully and deeply. Hold the breath for ten seconds before exhaling.
  • Food & Beverage: No major food interactions, but avoid consuming a large meal immediately before dosing if you experience oral irritation.
  • Missed dose: If a dose is forgotten, take it as soon as you remember unless the next scheduled dose is within 30 minutes; then skip the missed one to avoid double dosing.
  • Travel: Keep the inhaler at room temperature, away from humidity; the Diskus can be used at altitudes up to 2,500 m without loss of efficacy.

Understanding Side Effects and How to Manage Them

The most frequent local events-hoarseness, throat irritation, and oral candidiasis-arise because the corticosteroid deposits on the oropharyngeal mucosa. Rinsing the mouth with water and spitting, without swallowing, dramatically reduces these effects. Systemic effects such as adrenal suppression or reduced bone mineral density are rare at recommended doses but can occur with prolonged high-dose use; periodic monitoring of cortisol or bone density is prudent for long-term patients. Common β2-agonist-related symptoms-tremor, palpitations, or mild headaches-reflect salmeterol’s stimulation of β2 receptors in skeletal muscle and the cardiovascular system. Seek urgent care if you develop wheezing that worsens despite regular use, facial swelling, or signs of an allergic reaction such as rash or swelling of the lips.

Buying Advair Diskus from Our Online Pharmacy

Why Choose Our Service?

Our online pharmacy delivers a convenient, discreet route to a medication that can be hard to obtain in some Australian pharmacies, particularly for patients without private health cover.

Quality & Safety

We partner with licensed international distributors that comply with Australian Therapeutic Goods Administration standards and WHO Good Manufacturing Practices, ensuring each inhaler meets the same quality criteria as a pharmacy-filled product.

Pricing & Access

Because we source the medication in bulk, we can offer a price that is often 30 % lower than the retail cost of a brand-only supply. Repeat orders are eligible for a 10 % lifetime discount, helping you stay on therapy without financial strain.

Discreet Delivery

Orders are packed in unbranded, tamper-evident packaging. Express shipping reaches most Australian postcodes within 7 days; standard delivery takes up to three weeks.

Frequently Asked Questions

  • How often should I clean the Diskus device? Rinse the mouthpiece with warm water once weekly, shake off excess water, and let it air-dry. Do not use detergents or immerse the device.

  • Can I use a spacer with Advair Diskus? The Diskus is a breath-actuated dry-powder inhaler and is not compatible with a spacer; using a spacer would prevent powder dispersion and reduce dose delivery.

  • What is the difference between the 250 µg/50 µg and 500 µg/50 µg strengths? Both contain the same salmeterol dose; the higher fluticasone amount provides stronger anti-inflammatory coverage for patients whose symptoms persist despite the lower strength.

  • Do I need to use a rescue inhaler while on Advair Diskus? Yes. A short-acting β2-agonist such as salbutamol should be kept for acute symptom relief, as Advair Diskus is intended for maintenance, not rescue.

  • Is the inhaler safe for people with heart disease? Salmeterol’s β2 activity can cause a modest increase in heart rate; patients with uncontrolled arrhythmias should discuss risk versus benefit with their clinician.

  • Can children use Advair Diskus? The inhaler is approved for patients 12 years and older in Australia; younger children require age-appropriate alternatives such as a spacer-compatible aerosol.

  • Will the medication affect my blood pressure? Systemic absorption of fluticasone is minimal, so significant blood-pressure changes are uncommon, but monitoring is advisable if you are already on antihypertensives.

  • Why does my throat feel sore after each dose? The powder can irritate the oropharynx; rinsing and using a water-based mouthwash after each inhalation typically resolves the discomfort.

  • Is there a risk of tolerance to the bronchodilator component? Tolerance to salmeterol’s bronchodilatory effect is not usually observed, though chronic overuse may blunt the response; adhering to the prescribed schedule prevents this.

  • Can I switch from a dry-powder inhaler of the same ingredients to a metered-dose inhaler? While the active ingredients are identical, dosing accuracy may differ. Consult a pharmacist before converting, as the inhalation technique and particle size influence lung deposition.

  • Will insurance cover the medication? Many Australian private health funds list the drug under the Pharmaceutical Benefits Scheme; however, coverage varies, and a prescription is required for reimbursement.

Glossary

Dry-powder inhaler (DPI)
A device that releases powdered medication during a rapid, forceful inhalation, allowing drugs to reach the lower airways without the need for propellants.
Fluticasone propionate
A synthetic glucocorticoid that binds intracellular receptors to suppress airway inflammation.
Salmeterol
A long-acting β2-adrenergic agonist that relaxes airway smooth muscle, producing bronchodilation lasting up to 12 hours.

Disclaimer

The information provided about Advair Diskus is for general knowledge only and does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume readers are responsible adults capable of making informed health decisions. Our online pharmacy offers access to Advair Diskus for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.

External Resources about Advair Diskus


Information Prepared By

Sarah Jones
Tosin (Olalekan) Olaluwoye, MD, PhD